Linezolid is the first antibiotic of a new structural class, the oxazolidinones, to be approved for clinical use in 35 years. This antimicrobial agent is broadly effective against drug-resistant gram-positive pathogens which commonly cause infections. Linezolid merupakan antibiotik pertama dari kelas struktur baru, oksazolidinon, yang telah diluluskan untuk kegunaan klinikal setelah 35 tahun. Ejen anti-mikrob ini berkesan secara meluas terhadap patogen gram-positif rintang-antibiotik yang sering menjadi punca jangkitan bakteria
Linezolid is the main drug representative of the oxazolidinones, widely used in the clinical practic...
This study summarizes the linezolid susceptibility testing results for 7,429 Gram-positive pathogens...
Introduction: Staphylococcus aureus is one of the most commonly found hospital pathogen. With incre...
Linezolid is the only antibiotic available as an oral formulation for resistant staphylococcal infec...
Linezolid is the first oxazolidinone antibiotic to be licensed for treatment of Gram-positive infect...
Linezolid is the first oxazolidinone antibiotic to be licensed for treatment of Gram-positive infect...
Objectives: The aim of the study was to investigate the linezolid activity against clinical Gram-pos...
Methicillin-resistant Staphylococcus aureus (MRSA), an established nosocomial and emerging community...
Background : The increasing incidence of infectious diseases gives effect to uncontrolled use of ant...
Background: To study about the prevalence and anti-microbial susceptibility pattern of methicillin r...
The increase in the growth rate of MRSA as an enologie factor has been recorded worldwide in recent ...
The increase in the growth rate of MRSA as an enologie factor has been recorded worldwide in recent ...
Linezolid is an effective antimicrobial agent to treat methicillin-resistant Staphylococcus aureus (...
Treatment of Gram-positive bacterial infections is currently a therapeutic challenge because many of...
Linezolid is the main drug representative of the oxazolidinones, widely used in the clinical practic...
Linezolid is the main drug representative of the oxazolidinones, widely used in the clinical practic...
This study summarizes the linezolid susceptibility testing results for 7,429 Gram-positive pathogens...
Introduction: Staphylococcus aureus is one of the most commonly found hospital pathogen. With incre...
Linezolid is the only antibiotic available as an oral formulation for resistant staphylococcal infec...
Linezolid is the first oxazolidinone antibiotic to be licensed for treatment of Gram-positive infect...
Linezolid is the first oxazolidinone antibiotic to be licensed for treatment of Gram-positive infect...
Objectives: The aim of the study was to investigate the linezolid activity against clinical Gram-pos...
Methicillin-resistant Staphylococcus aureus (MRSA), an established nosocomial and emerging community...
Background : The increasing incidence of infectious diseases gives effect to uncontrolled use of ant...
Background: To study about the prevalence and anti-microbial susceptibility pattern of methicillin r...
The increase in the growth rate of MRSA as an enologie factor has been recorded worldwide in recent ...
The increase in the growth rate of MRSA as an enologie factor has been recorded worldwide in recent ...
Linezolid is an effective antimicrobial agent to treat methicillin-resistant Staphylococcus aureus (...
Treatment of Gram-positive bacterial infections is currently a therapeutic challenge because many of...
Linezolid is the main drug representative of the oxazolidinones, widely used in the clinical practic...
Linezolid is the main drug representative of the oxazolidinones, widely used in the clinical practic...
This study summarizes the linezolid susceptibility testing results for 7,429 Gram-positive pathogens...
Introduction: Staphylococcus aureus is one of the most commonly found hospital pathogen. With incre...